Literature DB >> 12384141

Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion.

Masahiro Saito1, Nobutaka Kiyokawa, Tomoko Taguchi, Kyoko Suzuki, Takaomi Sekino, Kenichi Mimori, Toyo Suzuki, Hideki Nakajima, Yohko U Katagiri, Junya Fujimura, Hiroo Fujita, Koichi Ishimoto, Yuichiro Yamashiro, Junichiro Fujimoto.   

Abstract

OBJECTIVE: Recent reports have indicated that monocytes express receptors for the granulocyte colony-stimulating factor (G-CSF). The direct effects of G-CSF on cytokine secretion in monocytes were examined.
MATERIALS AND METHODS: A monocytic cell line NOMO-1 that secretes multiple cytokines upon stimulation with lipopolysaccharide (LPS) was used. Normal human monocytes were purified by negative selection using magnetic beads. Cells pretreated with or without G-CSF were stimulated with LPS, and the subsequent concentrations of cytokines and chemokines in supernatants were determined by sandwich enzyme-linked immunosorbent assay.
RESULTS: NOMO-1 cells were found to express receptors for G-CSF. Although G-CSF stimulation did not induce cytokine secretion, pretreatment with G-CSF significantly attenuated LPS-stimulated secretion of the proinflammatory cytokines tumor necrosis factor-alpha and interleukin (IL)-12 in NOMO-1 cells. Simultaneously, however, G-CSF pretreatment apparently enhanced LPS-induced secretion of IL-10 and monocyte chemoattractant protein-1, whereas secretions of IL-1beta, IL-6, and IL-8 were unaffected. When normal human monocytes from healthy volunteers were similarly examined, marked individual variations in LPS-induced secretion of cytokines were observed. Although some exceptions exist, a similar tendency as to the effects of G-CSF treatment on cytokine secretions as that in NOMO-1 cells was observed in human monocytes.
CONCLUSIONS: Our data suggest that G-CSF directly affects monocytes and modulates their cytokine secretion. NOMO-1 cells can provide an alternate model for in vitro culture of monocytes to investigate the effects of G-CSF on cytokine secretion by these cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384141     DOI: 10.1016/s0301-472x(02)00889-5

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  14 in total

1.  Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma.

Authors:  Keiko Onda; Kazutoshi Iijima; Yohko U Katagiri; Hajime Okita; Masahiro Saito; Toshiaki Shimizu; Nobutaka Kiyokawa
Journal:  Int J Hematol       Date:  2010-04-29       Impact factor: 2.490

2.  Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.

Authors:  Marie Bleakley; Shelly Heimfeld; Lori A Jones; Cameron Turtle; Diane Krause; Stanley R Riddell; Warren Shlomchik
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-11       Impact factor: 5.742

3.  Characterization of monocyte-macrophage-lineage cells induced from CD34+ bone marrow cells in vitro.

Authors:  Kyoko Suzuki; Nobutaka Kiyokawa; Tomoko Taguchi; Hisami Takenouchi; Masahiro Saito; Toshiaki Shimizu; Hajime Okita; Junichiro Fujimoto
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

4.  Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15.

Authors:  Yu Xiong; Manon Mouginot; Loic Reppel; Chongsheng Qian; Jean-Francois Stoltz; Danièle Bensoussan; Véronique Decot
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

5.  Relationship between the cAMP levels in leukocytes and the cytokine balance in patients surviving gram negative bacterial pneumonia.

Authors:  Tomio Matsumoto; Keisuke Hayamizu; Seiji Marubayashi; Kiyoshi Shimizu; Aki Hamamoto; Tsuyoshi Yamaguchi; Junji Hashizume; Takashi Onabe; Toshimasa Asahara; Hideki Ohdan
Journal:  J Clin Biochem Nutr       Date:  2011-02-26       Impact factor: 3.114

6.  Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis.

Authors:  Eveliina Pollari; Ekaterina Savchenko; Merja Jaronen; Katja Kanninen; Tarja Malm; Sara Wojciechowski; Toni Ahtoniemi; Gundars Goldsteins; Raisa Giniatullina; Rashid Giniatullin; Jari Koistinaho; Johanna Magga
Journal:  J Neuroinflammation       Date:  2011-06-28       Impact factor: 8.322

7.  Granulocyte colony-stimulating factor (G-CSF) positive effects on muscle fiber degeneration and gait recovery after nerve lesion in MDX mice.

Authors:  Gustavo F Simões; Suzana U Benitez; Alexandre L R Oliveira
Journal:  Brain Behav       Date:  2014-08-05       Impact factor: 2.708

8.  Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients.

Authors:  Siw Johannesen; Bettina Budeus; Sebastian Peters; Sabine Iberl; Anne-Louise Meyer; Tina Kammermaier; Eva Wirkert; Tim-Henrik Bruun; Verena C Samara; Wilhelm Schulte-Mattler; Wolfgang Herr; Armin Schneider; Jochen Grassinger; Ulrich Bogdahn
Journal:  Front Neurol       Date:  2018-11-26       Impact factor: 4.003

9.  Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.

Authors:  Nana O Wilson; Wesley Solomon; Leonard Anderson; John Patrickson; Sidney Pitts; Vincent Bond; Mingli Liu; Jonathan K Stiles
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

Review 10.  Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection.

Authors:  Bao-Guo Xiao; Chuan-Zhen Lu; Hans Link
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.